In cancer cells, Nrf2 is an important player in the development of drug resistance, impairing drug-mediated oxidative stress and contributing to cancer cell survival, by inhibiting apoptosis and promoting cell proliferation [7,37]. Here, NFE2L2 is linked to cancer.